Zomato is not a buy at these levels, there is a room for more correction and there are better opportunities for investors
The market was down mainly due to consistent and aggressive selling from FIIs in the Asian markets
Brokerages have assigned buy rating on factors such as strong business model, robust bid pipeline, diversified order book and healthy balance sheet
Markets have been consolidating in a tight range and global markets are not supportive causing the decline
Glenmark Life Sciences IPO is open for subscription from July 27 to July 29, with a price band of Rs 695-720 per share
Till the time the Nifty stays above 15,600 on the closing basis, the markets remain in a buy-on-dips zone
Historically, large IPOs result in temporary upheavals and liquidity challenges in the market
Earnings were better than expectations and I believe the risk reward is favourable
Domestic equity markets opened in the red on Monday amid mixed global cues. The headline S&P BSE Sensex tumbled 63 points to quote at 52,913 levels in early deals while the broader Nifty50 held above the 15,800-mark at 15,840 levels, down 17 points. On the sectoral front, the buying was seen in the metal, pharma […]
With international markets supporting the move we could see Nifty showing some positive moves on a break above 15950